🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2804098 74 F OR 10/30/2024 FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8499BA
U8499BA
U8499BA
U8499BA




U8499BA
Diarrhoea, Dizziness, Feeling cold, Headache, Hot flush; Mobility decreased, Pyr... Diarrhoea, Dizziness, Feeling cold, Headache, Hot flush; Mobility decreased, Pyrexia, Tremor, Vomiting; Anal incontinence, Chills, Dizziness, Feeling of body temperature change, Insomnia; Tinnitus, Vomiting; Diarrhoea, Dizziness, Feeling cold, Headache, Hot flush; Mobility decreased, Pyrexia, Tremor, Vomiting; Anal incontinence, Chills, Dizziness, Feeling of body temperature change, Insomnia; Tinnitus, Vomiting; Breast cancer female, Breast mass, Diarrhoea, Dizziness, Vomiting More
Patient called in to report that she became very dizzy several hours after receiving her Influenza v... Patient called in to report that she became very dizzy several hours after receiving her Influenza vaccine. She reported she had dizziness, felt faint, and had to lay on the floor. She stated this had happened before. She reported she had vomiting and diarrhea while on the floor. She said she couldn't move. Later she felt better and said she was shaking with hot and cold flashes. She reported a headache that evening and took a tylenol which didn't help. Then at 5 am she took a motrin and her headache went away. She said during the evening she had a 100.5 degree fever. More
2802386 72 F NE 10/25/2024 COVID19
FLU3
COVID19
COVID19
FLUX
FLUX
 PFIZER\BIONTECH
SANOFI PASTEUR
PFIZER\BIONTECH
PFIZER\BIONTECH
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 NDC:00069-2432-
NDC:49281-0124-
Audiogram normal, Dizziness, Electronystagmogram; Audiogram normal, Dizziness, E... Audiogram normal, Dizziness, Electronystagmogram; Audiogram normal, Dizziness, Electronystagmogram; Brain fog, Dizziness, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory; Magnetic resonance imaging, Ultrasound scan; Brain fog, Dizziness, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory; Magnetic resonance imaging, Ultrasound scan More
Dizziness since 09/15/2024. Has not gone away and is continuous Dizziness since 09/15/2024. Has not gone away and is continuous
2794415 0.17 M TX 09/27/2024 DTPPVHBHPB
PNC15
RV5
DTPPVHBHPB
PNC15
RV5
 MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.
MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.
 47907AA
Y002963
X028575
47907AA
Y002963
X028575
Livedo reticularis; Livedo reticularis; Livedo reticularis; Livedo reticularis; ... Livedo reticularis; Livedo reticularis; Livedo reticularis; Livedo reticularis; Livedo reticularis; Livedo reticularis More
PATIENT BOTH LEG GOT MOTTLED AFTER RECEIVING THE VACCINES FOR ABOUT 20 MINUTES. *ARE WE ABLE TO GI... PATIENT BOTH LEG GOT MOTTLED AFTER RECEIVING THE VACCINES FOR ABOUT 20 MINUTES. *ARE WE ABLE TO GIVE HIS 4 MONTHS VACCINE? More
2792808 20 F MN 09/23/2024 DTPPVHBHPB
DTPPVHBHPB
 MSP VACCINE COMPANY
MSP VACCINE COMPANY
 U7296AA
U7296AA
No adverse event, Product administered to patient of inappropriate age; Product ... No adverse event, Product administered to patient of inappropriate age; Product administered to patient of inappropriate age More
No reaction No reaction
2780719 0.42 M GA 07/23/2024 DTPPVHBHPB
PNC15
DTPPVHBHPB
PNC15
 MSP VACCINE COMPANY
MERCK & CO. INC.
MSP VACCINE COMPANY
MERCK & CO. INC.
 U7623AA
X019324
U7623AA
X019324
Crying, Injection site nodule, Insomnia, Pyrexia; Crying, Injection site nodule,... Crying, Injection site nodule, Insomnia, Pyrexia; Crying, Injection site nodule, Insomnia, Pyrexia; Crying, Injection site erythema, Injection site mass, Pyrexia, Sleep disorder; Crying, Injection site erythema, Injection site mass, Pyrexia, Sleep disorder More
mom called on 07/22/2024 1318 to report her son cried for 3 days straight and never slept. Has a non... mom called on 07/22/2024 1318 to report her son cried for 3 days straight and never slept. Has a non-red knot on the RAT and ran a fever off/on and she alternated tyl/Ibuprofen and used cool compresses on the leg but is still concerned because the knot is still there. Mom reports not taking the child to the ER nor the pediatrician. More
2779988 M CA 07/17/2024 DTPPVHBHPB
PNC15
DTPPVHBHPB
PNC15
 MSP VACCINE COMPANY
MERCK & CO. INC.
MSP VACCINE COMPANY
MERCK & CO. INC.
 X019624
U7829AA
X019624
U7829AA
Swelling, Wheezing; Swelling, Wheezing; Swelling, Wheezing; Swelling, Wheezing Swelling, Wheezing; Swelling, Wheezing; Swelling, Wheezing; Swelling, Wheezing
Patient came in 07-16-2024. For swelling and wheezing. Patient came in 07-16-2024. For swelling and wheezing.
2777135 0.17 M SC 07/03/2024 DTPPVHBHPB
PNC15
RV5
DTPPVHBHPB
PNC15
RV5
 MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.
MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.
 U7623AA
X022028
1979980
U7623AA
X022028
1979980
Crying, Injection site induration, Injection site swelling, Irritability, Pyrexi... Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia; Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia; Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia; Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia; Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia; Crying, Injection site induration, Injection site swelling, Irritability, Pyrexia More
RIGHT LEG AT INJECTION SITE SWOLLEN AND HARD, HIGH FEVER GREATER THAN 3 DAYS, IRRITABILITY AND CONST... RIGHT LEG AT INJECTION SITE SWOLLEN AND HARD, HIGH FEVER GREATER THAN 3 DAYS, IRRITABILITY AND CONSTANT CRYING. More
2819430 0.17 F 01/06/2025 DTAPHEPBIP
 GLAXOSMITHKLINE BIOLOGICALS
 X9HS4
Expired product administered Expired product administered
gave an expired vaccine; This non-serious case was reported by a nurse via call center representativ... gave an expired vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 2-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number X9HS4, expiry date 25-MAR-2024) for prophylaxis. On an unknown date, the patient received Pediarix. On an unknown date, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: gave an expired vaccine). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-DEC-2024 The licensed practical nurse reported that one of their nurses in their office gave an expired dose of Pediarix vaccine , which led to expired vaccine used. More
2819431 F MO 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Varicella Varicella
developed chicken pox on her feet; This non-serious case was reported by a consumer via call center ... developed chicken pox on her feet; This non-serious case was reported by a consumer via call center representative and described the occurrence of chickenpox in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced chickenpox (Verbatim: developed chicken pox on her feet). The outcome of the chickenpox was unknown. It was unknown if the reporter considered the chickenpox to be related to Shingrix. It was unknown if the company considered the chickenpox to be related to Shingrix. Additional Information: GSK Receipt Date: 13-DEC-2024 The patient self-reported this case. The patient received the first dose of Shingrix she developed chicken pox on her feet. More
2819432 F TX 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 E7335
Inappropriate schedule of product administration Inappropriate schedule of product administration
1st dose was in "January 2022, 2nd dose was October 2024 of this year; This non-serious case wa... 1st dose was in "January 2022, 2nd dose was October 2024 of this year; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a adult female patient who received Herpes zoster (Shingrix) (batch number E7335, expiry date 15-JUN-2026) for prophylaxis. Previously administered products included Shingrix (received 1st dose in January 2022). In OCT-2024, the patient received the 2nd dose of Shingrix. In OCT-2024, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose was in "January 2022, 2nd dose was October 2024 of this year). The outcome of the drug dose administration interval too long was unknown. Additional Information: GSK Receipt Date: 16-DEC-2024 The pharmacist reported that the patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. The Vaccine Administration Facility was the same as Primary Reporter. More
2819433 F SD 01/06/2025 HIBV
 GLAXOSMITHKLINE BIOLOGICALS
 YJ4KC
Expired product administered Expired product administered
Expired dose administered; This non-serious case was reported by a nurse via call center representat... Expired dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-month-old female patient who received Hib (Hiberix) (batch number YJ4KC, expiry date 14-DEC-2024) for prophylaxis. On 16-DEC-2024, the patient received the 4th dose of Hiberix. On 16-DEC-2024, an unknown time after receiving Hiberix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt date: 16-DEC-2024 Nurse stated they administered an expired dose of Hiberix, which led to expired vaccine used. The reporter explained that the patient already received 3 prior doses of Haemophilus influenzae type b vaccine, but they did not have dates of administration of those 3 doses. The reporter consented to follow up. More
2819434 18 F WA 01/06/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 ZP72S
Expired product administered Expired product administered
received an expired Engerix-B Vaccine; This non-serious case was reported by a other health professi... received an expired Engerix-B Vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-year-old female patient who received HBV (Engerix B) (batch number ZP72S, expiry date 15-DEC-2024) for prophylaxis. On 16-DEC-2024, the patient received Engerix B (intramuscular). On 16-DEC-2024, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: received an expired Engerix-B Vaccine). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-DEC-2024 The reporter calling to report one of their patients received an expired Engerix-B Vaccine at the time of reporting, which led to expired vaccine used. The reporter consented to follow up. More
2819435 3 F TN 01/06/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
 LG722
Expired product administered Expired product administered
expired dose of Priorix was accidentally given to a patient; This non-serious case was reported by a... expired dose of Priorix was accidentally given to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 3-year-old female patient who received MMR (Priorix) (batch number LG722, expiry date 01-DEC-2024) for prophylaxis. On 16-DEC-2024, the patient received the 1st dose of Priorix. On 16-DEC-2024, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: expired dose of Priorix was accidentally given to a patient). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:16-DEC-2024 A nurse practitioner contacted GSK to report that an expired dose of Priorix was accidentally given to a patient , which led to expired vaccine used. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter. More
2819436 U LA 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
administer to a patient less than 50 years of age; This non-serious case was reported by a other hea... administer to a patient less than 50 years of age; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administer to a patient less than 50 years of age). The outcome of the inappropriate age at vaccine administration was unknown. Additional Information: GSK Receipt Date: 18-DEC-2024 The medical office manager reported that Shingrix was administered to a patient less than 50 years of age. The patient received a dose of Shingrix at an inappropriate age, which led to inappropriate age at vaccine administration. More
2819437 82 F 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 HN24H
Inappropriate schedule of product administration Inappropriate schedule of product administration
administration of a second dose of Shingrix 2 years after the initial dose.; This non-serious case w... administration of a second dose of Shingrix 2 years after the initial dose.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 82-year-old female patient who received Herpes zoster (Shingrix) (batch number HN24H) for prophylaxis. Previously administered products included Shingrix (received 1st dose 2 years ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: administration of a second dose of Shingrix 2 years after the initial dose.). The outcome of the drug dose administration interval too long was unknown. Additional Information: GSK Receipt Date: 18-DEC-2024 The healthcare professional reported about the administration of a second dose of Shingrix 2 years after the initial dose. The Vaccine Administration Facility was the same as Primary Reporter. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. More
2819438 40 M MI 01/06/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 95DB2
Expired product administered Expired product administered
a patient accidentally received their first Havrix dose, but it was expired; This non-serious case w... a patient accidentally received their first Havrix dose, but it was expired; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 40-year-old male patient who received HAV (Havrix) (batch number 95DB2, expiry date 13-DEC-2024) for prophylaxis. On 23-DEC-2024, the patient received the 1st dose of Havrix. On 23-DEC-2024, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: a patient accidentally received their first Havrix dose, but it was expired). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-DEC-2024 The reporter called to report that a patient accidentally received their first Havrix dose, but it was expired, which led to expired vaccine used. The data about the vaccine, patient and event given. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. More
2819439 F 01/06/2025 FLUX
 UNKNOWN MANUFACTURER
Diarrhoea, Influenza Diarrhoea, Influenza
Diarrhea; Initial information received on 01-Jan-2025 regarding an unsolicited valid social media no... Diarrhea; Initial information received on 01-Jan-2025 regarding an unsolicited valid social media non-serious case received from a Patient. This case involves Adult female patient who experienced diarrhea after receiving Influenza Vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in Aug-2024, the patient received an unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (strength, expiry date, lot number not reported) via unknown route in unknown administration site for immunization.Information regarding batch number corresponding to the one at time of event occurrence is requested. On an unknown date the patient developed diarrhea (diarrhoea) (unknown latency) following the administration of Influenza Vaccine. Reportedly,Had it in August, the big one "flu/covid"..diarrhea for 10 days. Today was diagnosed with the "flu". Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (Diarrhea). At time of reporting, the outcome was Unknown for the event diarrhea. More
2819449 M NJ 01/06/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 745P4
Nasopharyngitis, Underdose Nasopharyngitis, Underdose
development of cold like symptom; they are not sure the patient received a full dose/underdose; This... development of cold like symptom; they are not sure the patient received a full dose/underdose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of cold symptoms in a 3-year-old male patient who received Flu Seasonal TIV Dresden (Fluarix 2024-2025 season) (batch number 745P4, expiry date 30-JUN-2025) for prophylaxis. On 07-DEC-2024, the patient received Fluarix 2024-2025 season. On 07-DEC-2024, an unknown time after receiving Fluarix 2024-2025 season, the patient experienced underdose (Verbatim: they are not sure the patient received a full dose/underdose). On an unknown date, the patient experienced cold symptoms (Verbatim: development of cold like symptom). The outcome of the cold symptoms and underdose were unknown. It was unknown if the reporter considered the cold symptoms to be related to Fluarix 2024-2025 season and Fluarix Pre-Filled Syringe Device. It was unknown if the company considered the cold symptoms to be related to Fluarix 2024-2025 season and Fluarix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-DEC-2024 Pharmacist reported that in the weekend his colleague administered a Fluarix vaccine to a three-year-old male patient. They were not sure the patient received a full dose, they wanted advise for this situation. Pharmacist also reported development of cold like symptom (not specified in the call) by this patient as well. Vaccine detail, vaccination date and patient demographics were retrieved during this call. No further information was obtained during this call. The patient did not receive the full dose which led to underdose. More
2819453 45 F IA 01/06/2025 TDAP
TDAP
TDAP
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8015AA
U8015AA
U8015AA
Arthralgia, Asthenia, Chills, Fatigue, Hyperhidrosis; Injection site erythema, I... Arthralgia, Asthenia, Chills, Fatigue, Hyperhidrosis; Injection site erythema, Injection site swelling, Myalgia, Nausea, Palpitations; Pyrexia, Rash, Rash erythematous More
Patient woke up at 2:00 am on 1/3/25 with low grade fever, chills, sweats, major muscle and joint pa... Patient woke up at 2:00 am on 1/3/25 with low grade fever, chills, sweats, major muscle and joint pain, fatigue, racing heart, nausea and weakness. Lasted 24 hours and had injection site redness, swelling. Broke out with red bumps on left flank and abdomen. More
2819495 M NY 01/06/2025 DTOX
DTOX
HIBV
HIBV
MMRV
MMRV
TTOX
TTOX
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER







Anti-vimentin antibody positive, Antibody test, Blast cell count decreased, Bloo... Anti-vimentin antibody positive, Antibody test, Blast cell count decreased, Blood immunoglobulin G decreased, Bone lesion; Cytokine abnormal, Measles antibody negative, Rubella antibody negative; Anti-vimentin antibody positive, Antibody test, Blast cell count decreased, Blood immunoglobulin G decreased, Bone lesion; Cytokine abnormal, Measles antibody negative, Rubella antibody negative; Anti-vimentin antibody positive, Antibody test, Blast cell count decreased, Blood immunoglobulin G decreased, Bone lesion; Cytokine abnormal, Measles antibody negative, Rubella antibody negative; Anti-vimentin antibody positive, Antibody test, Blast cell count decreased, Blood immunoglobulin G decreased, Bone lesion; Cytokine abnormal, Measles antibody negative, Rubella antibody negative More
absent specific antibody response to all vaccines tested; This literature marketed report has been r... absent specific antibody response to all vaccines tested; This literature marketed report has been received from the authors of a published literature article, titled as stated below, referring to a male child. The patient's concurrent conditions included cherubism, developmental delay, autism, dysmorphic face, downturned and lowset ears, down-slanted eye, tethered tongue base, generalized joint hypermoblilty, cutis laxa, asthma, allergic rhinitis, gastric outlet obstruction from pyloric stenosis, a palate fistula with velopharyngeal insufficiency since age 9, and an aortic aneurysm involving the ascending aorta and intra-abdominal descending aorta at age 10. His medical history included recurrent episodes of otitis media, mastoiditis, sinusitis, several bilateral myringotomy and tubes surgeries since age 3, several functional several functional endoscopic sinus surgeries with sinus debridement since age 4, right tympanomastoidectomy at age 5, several instances of left mastoid debridement from ages 5 to 6, episodes of nodular, vesicular, pustular, or pannicular rash, recurrent episodes granuloma annulare, recurrent episodes of onychomycosis, paronychia, and cellulitis complicated by right third toe amputation at age 9 for an inflammatory mass associated with Staphylococcus pseudintermedius. On unknown dates, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (manufacturer unknown), measles, mumps, rubella and varicella (oka-merck) virus vaccine live (manufacturer unknown), tetanus vaccine (unspecified), diphtheria vaccine (unspecified), Streptococcus pneumoniae vaccine (unspecified) and rubeola vaccine (unspecified) (dose, route of administration, anatomical location, lot# and expiry date were not reported); all the suspect vaccines were administered for prophylaxis. On an unknown date, in radiologic evaluation, the patient was found to have bilateral expansile lucent bone lesions within the maxilla and mandibular rami soap-bubble appearance. Incisional biopsy showed bland cellular fibroproliferative ovoid to spindle-shaped stromal cells with associated scattered multinucleated giant cells, irregular spicules of lamellar and woven bone, and small-caliber intralesional blood vessels surrounded by cuff-like deposits of eosinophilic material. Spindled lesional cells analysis was positive for vimentin, which confirmed the lesion's mesenchymal origin, and negative for S100, smooth muscle actin, and CD1a, which ruled out smooth muscle or myofibroblast proliferations, Langerhans cell histiocytosis, and nerve sheath or melanocytic tumors. Giant cells analysis was positive for CD68. The Ki-67 proliferation index was low (less than 3%). Clinical laboratory results demonstrated that total B cell count was decreased, and CD27+ memory B cells were decreased, precluding the assessment of switched versus unswitched memory T cells. The patient's immunoglobin G (IgG) was less than 61 mg/dL (decreased), and the specific antibody response was absent to all vaccines tested; tetanus IgG was less than 0.1 IU/mL, diphtheria IgG was less than 0.1 IU/mL, Haemophilus influenzae B IgG was less than 0.15 ug/mL, measles IgG was less than 25 AU/mL, rubella IgG was less than 1 (index), varicella zoster vaccine response was less than 135.000 (index), rubeola vaccine response was absent, and Streptococcus pneumoniae vaccine response was absent. Natural killer (NK) function was absent. A limited serum inflammatory cytokine panel showed only that soluble interleukin-2 (IL-2) receptor level was 1318 pg/mL (mildly elevated). Exome sequencing showed a heterozygous phospholipase C gamma 2 (PLCG2) variant. The outcome of the event of vaccine induced antibody absent was not reported. The authors considered the event of vaccine induced antibody absent as related to suspect vaccines. A copy of the published article is attached as further documentation of the patient's experience. This is one of two reports referring to the same literature article. Literature Report: Lot # is being requested and will be submitted if received.; Sender's Comments: US-009507513-2412USA009745: More
2819496 U CT 01/06/2025 MMR
 MERCK & CO. INC.
 X022410
Expired product administered, No adverse event Expired product administered, No adverse event
No additional AE; Expired MMR II was administered on 18-DEC-2024 with an expiration date of 06-NOV-2... No additional AE; Expired MMR II was administered on 18-DEC-2024 with an expiration date of 06-NOV-2024 (Lot # X022410); This spontaneous report was received from the nurse and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-DEC-2024, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, recombinant human albumin (rHa), valid lot # X022410, expiration date: 06-NOV-2024, administered for prophylaxis (dose, strength and route of administration were not provided) (expired product administered). There were no reported signs/symptoms of adverse effects from administered dose. No additional adverse event (AE) was reported. More
2819497 74 F NY 01/06/2025 COVID19
 MODERNA
Rash, Rash erythematous, Rash papular Rash, Rash erythematous, Rash papular
Starting at 6:00 am 10/17/2024 red, burning, raised rash on face (like having a very bad sunburn but... Starting at 6:00 am 10/17/2024 red, burning, raised rash on face (like having a very bad sunburn but in this instance I was not in the sun that day for previous days). More
2819498 53 M CT 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Rash vesicular Rash vesicular
Blistery rash Blistery rash
2819499 24 M TN 01/06/2025 COVID19
FLU3
 MODERNA
SEQIRUS, INC.
AW1605C
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Patient had already received an annual influenza vaccine prior to 12/5/24. This nurse did not realiz... Patient had already received an annual influenza vaccine prior to 12/5/24. This nurse did not realize that. This nurse gave a second dose on 12/5/24. More
2819501 71 F FL 01/06/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH









Bone pain, Breast pain, Chest X-ray normal, Injection site pain, Laboratory test... Bone pain, Breast pain, Chest X-ray normal, Injection site pain, Laboratory test; Limb discomfort, Oxygen saturation decreased, Pain; Asthenia, Bone pain, Breast pain, Bronchitis, Chest pain; Fatigue, Joint range of motion decreased, Muscle strain, Oxygen saturation, Pain in extremity; Panic disorder, Sleep disorder due to general medical condition, insomnia type, Vaccination site pain, X-ray; Bone pain, Breast pain, Chest X-ray normal, Injection site pain, Laboratory test; Limb discomfort, Oxygen saturation decreased, Pain; Asthenia, Bone pain, Breast pain, Bronchitis, Chest pain; Fatigue, Joint range of motion decreased, Muscle strain, Oxygen saturation, Pain in extremity; Panic disorder, Sleep disorder due to general medical condition, insomnia type, Vaccination site pain, X-ray More
after the vaccine the pain came into the arm around the injection site into the bone and it went aro... after the vaccine the pain came into the arm around the injection site into the bone and it went around the breast. Used heating pads to try to help with the pain. On 12/19/24 went to hospital, Was given chest xray which was negative. Her O2 level was low so was kept until 12/21/24. She was given IV with antibiotics. They told her they could not find anything wrong with her arm and told her they felt like she must have slept wrong but she feels like it was from the injection since it started at the injection site and the pain moved into the bone in the arm and then down around the breast. Now when lifting the arm there is a feeling of pressure and if there is anymore extension then that is when she starts having the pain in the arm and breast. She was discharged with a precription of zithromax. She is going to follow with PCP on 1/22/25 and her pulmonologist Dr., MD. on 1/16/25. More
✓
2819502 60 M MN 01/06/2025 COVID19
COVID19
 JANSSEN
MODERNA
 203A21A
059H21A
SARS-CoV-2 test, Unevaluable event; SARS-CoV-2 test, Unevaluable event SARS-CoV-2 test, Unevaluable event; SARS-CoV-2 test, Unevaluable event
Unknown Unknown
2819503 66 F NY 01/06/2025 FLU4
FLU4
 SANOFI PASTEUR
SANOFI PASTEUR
 U8429DA
U8429DA
Autoimmune disorder, Dermatitis allergic, Herpes zoster, Injection site erythema... Autoimmune disorder, Dermatitis allergic, Herpes zoster, Injection site erythema, Injection site pain; Injection site pruritus, Injection site swelling, Injection site vesicles More
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Inject... Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Autoimmune Disease (diagnosed by MD)-Medium, Systemic: 2 Oblong blisters at injection site-Severe, Additional Details: Recent (>30 days) Shingles infection More
2819504 62 F OH 01/06/2025 COVID19
 PFIZER\BIONTECH
 GJ6796
Asthenia, Mobility decreased Asthenia, Mobility decreased
Systemic: "Weak in bed"-Medium, Systemic: Weakness-Medium Systemic: "Weak in bed"-Medium, Systemic: Weakness-Medium
2819505 29 F CA 01/06/2025 COVID19
 PFIZER\BIONTECH
 lm2224
Dizziness, Hypotension, Vomiting Dizziness, Hypotension, Vomiting
Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypotension-Medium, Systemic: Vomiting-Medium Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypotension-Medium, Systemic: Vomiting-Medium
2819506 24 F MD 01/06/2025 COVID19
COVID19
 MODERNA
MODERNA
 3043822
3043822
Chills, Fatigue, Headache, Injection site erythema, Insomnia; Lethargy, Pain Chills, Fatigue, Headache, Injection site erythema, Insomnia; Lethargy, Pain
Site: Redness at Injection Site-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Mild... Site: Redness at Injection Site-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Headache-Mild, Systemic: Unable to Sleep-Severe More
2819507 16 F MI 01/06/2025 FLUC4
 SEQIRUS, INC.
 388522
Syncope, Unresponsive to stimuli Syncope, Unresponsive to stimuli
Systemic: Fainting / Unresponsive-Severe, Additional Details: PATIENT FAINTED FOR 2 MINUTES AFTER VA... Systemic: Fainting / Unresponsive-Severe, Additional Details: PATIENT FAINTED FOR 2 MINUTES AFTER VACCINATION, BUT WOKE UP AFTERWARDS, Other Vaccines: VaccineTypeBrand: BOOSTRIX TDAP; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN More
2819508 63 F NY 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 e7335
Injection site pruritus, Pruritus Injection site pruritus, Pruritus
Site: Itching at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)... Site: Itching at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: no exeternal rash seen but pt has extreme itching-Severe More
2819509 17 F FL 01/06/2025 FLUC4
FLUC4
FLUC4
 SEQIRUS, INC.
SEQIRUS, INC.
SEQIRUS, INC.
 391416
391416
391416
Blood glucose normal, Dizziness, Dysarthria, Fatigue, Flushing; Hyperhidrosis, L... Blood glucose normal, Dizziness, Dysarthria, Fatigue, Flushing; Hyperhidrosis, Lethargy, Lymphadenopathy, Presyncope, Syncope; Unresponsive to stimuli More
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainti... Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Lymph Node Swelling-Severe, Additional Details: After getting vaccinated with the Meningitis and Flu vaccines, patient had her 1st vagal episode at approximately 1:09pm on 12/28/24. She was revived within minutes by her putting her legs up and alcohol swabs. 2nd vagal episode was at approximately 1:25pm in the waiting room. Patient was drenched with sweat, having slurred speech. 911 called, arrived at 1:40pm. Paramedics put her on a stretcher to her Mom's car, after confirming: vitals, blood sugar all normal. , Other Vaccines: VaccineTypeBrand: Sanofi MenQuadfi; Manufacturer: Sanofi; LotNumber: 391416 ; Route: ; BodySite: left deltoid; Dose: 1; VaxDate: 12/28/2024 More
2819510 61 F FL 01/06/2025 PNC20
 PFIZER\WYETH
 LG5579
Injection site bruising, Injection site pain, Injection site reaction, Joint swe... Injection site bruising, Injection site pain, Injection site reaction, Joint swelling, Rash More
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injec... Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Told to take claritin and to keep watch on her left arm and if it gets bigger or starts to feel hot to go to the dr's office., Other Vaccines: VaccineTypeBrand: Flucelvax Trival 2024-20245 Syr; Manufacturer: Seqirus; LotNumber: 391416; Route: IM; BodySite: Left Arm; Dose: 1; VaxDate: 12/23/2024 More
2819511 79 F RI 01/06/2025 COVID19
 MODERNA
 3042560
Arthralgia, Asthenia, Gait inability, Injection site erythema, Pyrexia Arthralgia, Asthenia, Gait inability, Injection site erythema, Pyrexia
Site: Redness at Injection Site-Mild, Systemic: Fever-Medium, Systemic: Joint Pain-Medium, Systemic:... Site: Redness at Injection Site-Mild, Systemic: Fever-Medium, Systemic: Joint Pain-Medium, Systemic: Weakness-Medium, Additional Details: Right hip pain with inability to walk for 2 days post injection, More
2819512 68 U WI 01/06/2025 HEPA
 MERCK & CO. INC.
 X025485
No adverse event, Underdose No adverse event, Underdose
No additional AE; an adult patient was given a pediatric dose of VAQTA; This spontaneous report was ... No additional AE; an adult patient was given a pediatric dose of VAQTA; This spontaneous report was received from a medical assistant and refers to a 68-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-DEC-2024, the patient was vaccinated with a pediatric dose of hepatitis A vaccine, inactivated (VAQTA) intramuscular injection (Incorrect dose administered), administered for prophylaxis (lot #X025485, has been verified to be a valid lot number, expiration date reported and upon internal validation both confirmed as 13-MAY-2025; strength, dose and route of administration were not provided). No adverse side effects were reported. There was no additional adverse event (AE) or product quality complaint (PQC) provided. More
2819513 27 M MA 01/06/2025 FLUC4
 SEQIRUS, INC.
 946639
Hypoaesthesia Hypoaesthesia
Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Pt got covid and ... Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Pt got covid and flu vaccine at 11am 12/29/24 then called the pharmacy at 6pm. Pt stated he was watching tv when he noticed numbness in his feet he waited an hour before calling the pharmacy to ask what he should do. I (the rph that day) told the pt if it continues or gets worse to call his doctor tomorrow., Other Vaccines: VaccineTypeBrand: covid; Manufacturer: moderna; LotNumber: 3043836; Route: im; BodySite: left arm; Dose: 1; VaxDate: 12/29/2024 More
2819514 24 F NY 01/06/2025 HPV9
 MERCK & CO. INC.
 y007322
Asthenia, Dizziness Asthenia, Dizziness
Systemic: Dizziness / Lightheadness-Mild, Systemic: Weakness-Mild Systemic: Dizziness / Lightheadness-Mild, Systemic: Weakness-Mild
2819515 15 F TX 01/06/2025 COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
 3043335
3043335
3043335
Condition aggravated, Confusional state, Fatigue, Flushing, Hyperhidrosis; Immed... Condition aggravated, Confusional state, Fatigue, Flushing, Hyperhidrosis; Immediate post-injection reaction, Injection site pain, Lethargy, Loss of consciousness, Tremor; Vomiting More
Site: Pain at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Exhaustion / Lethargy-Mild, S... Site: Pain at Injection Site-Mild, Systemic: Confusion-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Systemic: Vomiting-Mild, Additional Details: Patient passed out immediately when covid vaccine was administered, assisted to lay down in bed, then immediately became awake and alert, patient a bit confused, unsure of what happened. Patient then had large amount of emesis, she was afebrile. Patient was stabilized after incident, awake, oriented, vital signs stable at 107/76, pulse oximetry 99% on room air. Mom present at time of incident., Other Vaccines: VaccineTypeBrand: Flucelvax; Manufacturer: Seqirus; LotNumber: 388534; Route: im; BodySite: ld; Dose: unknown; VaxDate: 12/30/2024 More
2819516 75 F CA 01/06/2025 RSV
RSV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 4F45Z
4F45Z
Abdominal pain upper, Asthenia, Fatigue, Headache, Injection site pain; Injectio... Abdominal pain upper, Asthenia, Fatigue, Headache, Injection site pain; Injection site swelling, Lethargy, Peripheral swelling More
Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion /... Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT SAID HAVING HEADACHE, STOMACH ACHE, SORED, SWOLLEN ARM, WEAKNESS AND FELT TIRED More
2819517 76 F CT 01/06/2025 COVID19
 PFIZER\BIONTECH
 LE1811
Hypoaesthesia, Injection site pain, Pain in extremity Hypoaesthesia, Injection site pain, Pain in extremity
Site: Pain at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Addi... Site: Pain at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: Patient reports left arm pain and left hand numbness after previous covid vaccine. More
2819518 70 M TX 01/06/2025 COVID19
 PFIZER\BIONTECH
 HM7010
Pyrexia Pyrexia
Systemic: Fever-Medium, Additional Details: Patient's wife reports after COVAX she and her husb... Systemic: Fever-Medium, Additional Details: Patient's wife reports after COVAX she and her husband became very sick, & experienced high fevers. More
2819519 67 F PA 01/06/2025 COVID19
 MODERNA
 8080803
Infection, Injection site pruritus, Injection site swelling, Pruritus Infection, Injection site pruritus, Injection site swelling, Pruritus
Site: Itching at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: infection... Site: Itching at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: infection and itiching on whole arm after vaccine-Medium, Additional Details: patient was given azithromycin 250mg, prednisone 20mg, ibuprofen 600mg and cetirizine 10mg on 12/31/24 by PCP, Other Vaccines: VaccineTypeBrand: shingrix; Manufacturer: gsk; LotNumber: 445tk; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN More
2819520 65 M TX 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 2737j
Vomiting Vomiting
Systemic: Vomiting-Medium, Additional Details: Patient threw up the evening after the receiving the ... Systemic: Vomiting-Medium, Additional Details: Patient threw up the evening after the receiving the vaccine and the next day. More
2819521 54 F NC 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 9r397
Immediate post-injection reaction, Injection site pain Immediate post-injection reaction, Injection site pain
Site: Pain at Injection Site-Severe, Additional Details: immediately after adminstering vaccine into... Site: Pain at Injection Site-Severe, Additional Details: immediately after adminstering vaccine into patient's left arm, she felt intense pain and burning. She stated that she could feel the vaccine go into her arm and that i pushed to hard More
2819522 70 F FL 01/06/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 4BN95
Contusion, Dizziness, Fall, Seizure, Tongue biting Contusion, Dizziness, Fall, Seizure, Tongue biting
Systemic: Seizure-Medium, Additional Details: PATIENT REPORTS SEIZURE DURING SHOWER ON 12/25/24 (A C... Systemic: Seizure-Medium, Additional Details: PATIENT REPORTS SEIZURE DURING SHOWER ON 12/25/24 (A COUPLE OF DAYS AFTER VACCINES) CAUSING HER TO FALL OUT OF THE SHOWER. BRUISED HEAD, ARM, AND LEGS, BIT TONGUE. WAS BROUGHT TO THE ER WHERE SEIZURE DIAGNOSED. STILL FEELING "WOOZY" AS OF TODAY, 01/01/25 , Other Vaccines: VaccineTypeBrand: INACTIVATED FLU (FLUZONE HIGH-DOSE TRIVALENT 2024-25); Manufacturer: SANOFI-PASTEUR; LotNumber: U8515DA; Route: IM; BodySite: LEFT DELTOID (ARM); Dose: ; VaxDate: UNKNOWN More
2819523 61 F PA 01/06/2025 FLU4
 SANOFI PASTEUR
 ut8408la
Arthralgia, Asthenia, Injection site pain, Speech disorder Arthralgia, Asthenia, Injection site pain, Speech disorder
Site: Pain at Injection Site-Mild, Systemic: Difficlty with speach-Medium, Systemic: Joint Pain-Medi... Site: Pain at Injection Site-Mild, Systemic: Difficlty with speach-Medium, Systemic: Joint Pain-Medium, Systemic: Weakness-Medium, Additional Details: previously reported but pt not contacted, Other Vaccines: VaccineTypeBrand: fluzone trivalent pf syringe; Manufacturer: sanofi pasteur; LotNumber: ut8408la; Route: IM; BodySite: Left Deltoid; Dose: ; VaxDate: UNKNOWN More
2819524 67 M PA 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 m4dy4
Tinnitus Tinnitus
Systemic: Tinnitus-Severe, Additional Details: Previously reported, but pt was never contacted. pati... Systemic: Tinnitus-Severe, Additional Details: Previously reported, but pt was never contacted. patient would like to be contacted. patient reported long term tinnitus. please contact pt, Other Vaccines: VaccineTypeBrand: shingrix; Manufacturer: GlaxoSmithKline; LotNumber: M4DY4; Route: IM; BodySite: Left Deltoid; Dose: ; VaxDate: UNKNOWN More
2819525 64 F AL 01/06/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 g97y2
Injection site cellulitis, Injection site erythema, Injection site pain, Injecti... Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling More
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injec... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient experienced intense redness and swelling at the injection site that she and her doctor think in cellulitis and will require an antibiotic More
2819526 59 M IN 01/06/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
 342rc
Injection site pain Injection site pain
Site: Pain at Injection Site-Mild Site: Pain at Injection Site-Mild
📋 Privacy Policy & Data Disclaimer